Target intelligence / Profile preview

AKT3 intronic transcript 1 (non-protein coding) (AKT3-IT1)

Target
AKT3-IT1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein-coding RNA
01

Overview

AKT3 intronic transcript 1 (AKT3-IT1) is a long non-coding RNA transcribed from an intronic region of the AKT3 gene. The AKT3 gene encodes a serine/threonine kinase that is crucial in controlling brain development, cell proliferation, survival, metabolism, and DNA repair, particularly with implications in cancer progression. Like other lncRNAs originating near or within protein-coding genes, AKT3-IT1 may participate in regulating transcription, splicing, or translation of AKT3 or other genes, but its direct biological functions and disease associations have not been specifically established in the literature. The broader class of AKT-regulating lncRNAs plays important roles in signaling pathways relevant to cancer, cell death, and therapy resistance; by analogy, AKT3-IT1 may perform similar modulatory functions, although no specific experimental data are available for this transcript. - There is no evidence that AKT3-IT1 is a therapeutically targeted molecule. - There is no indication that the name is incorrect or confused, although the actual function and clinical relevance of AKT3-IT1 remain obscure.

Other names
AKT3 intronic transcript 1 (non-protein coding)AKT3-IT1
02

Mechanism of action

Not applicable for AKT3-IT1, as it is not a drug target; however, lncRNAs modulating AKT3 may influence cell signaling, cell survival, and therapy resistance pathways indirectly

03

Biological functions

Potential modulation of AKT3 gene expressionMay be involved in regulation of cellular processes (by analogy to other lncRNAs associated with AKT family genes: apoptosis, autophagy, cell proliferation, DNA damage response, and metabolic regulation)Specific direct function for AKT3-IT1 remains to be clarified in published literature
04

Disease associations

Potential roles in cancer, inferred from association with AKT3 and the general role of AKT-related lncRNAs in tumorigenesis and cell function regulationDirect evidence for AKT3-IT1 in specific diseases is lacking
05

Safety considerations

None documented; as a non-coding RNA, AKT3-IT1 is generally relevant as a research molecule rather than a therapeutic target
06

Interacting drugs

None known; lncRNAs such as AKT3-IT1 are not direct targets of approved therapeutic drugs
07

Biomarkers

None known for AKT3-IT1 specifically

Beyond the preview

Go deeper on AKT3 intronic transcript 1 (non-protein coding) (AKT3-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AKT3 intronic transcript 1 (non-protein coding) (AKT3-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call